Awareness of nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD) is low among Americans who have risks associated with the diseases, according to a survey presented at the NASH Summit in Boston. Many clinical trials are currently underway regarding pharmacologic interventions in an area where diet and lifestyle are failing to curb rising incidence
Obese African-American youths had more severe nonalcoholic fatty liver disease, but overall NAFLD was more common among obese white or Hispanic youth, according to a study in Hepatology. Earlier studies have shown Hispanic adults and children had the highest rates of NAFLD, while African-Americans have a lower likelihood of developing hepatic fat accumulation. See the
A study in JAMA Neurology linked fatty liver disease to an accelerated risk of atrophic brain disease compared to normal aging. Researchers said NAFLD did not appear to be linked to indications of other brain injuries or stroke. The reduced brain volume linked to non-alcoholic fatty liver disease (NAFLD) is equivalent to an extra 4.2
NAFLD Linked to Higher Incidence Rates of Cancer Significantly associated with HCC, colon cancer in men, and breast cancer in women Nonalcoholic fatty liver disease (NAFLD) was tied to an increased risk of hepatocellular carcinoma (HCC), colorectal cancer in men, and breast cancer in women, South Korean researchers found. Adjusted results from an observational meta-analysis
Researchers link risk of gestational diabetes and glucose intolerances to nonalcoholic fatty liver disease
A Canadian study in The American Journal of Gastroenterology showed that women with ultrasound evidence of nonalcoholic fatty liver disease (NAFLD) during their early pregnancy were more likely to develop gestational diabetes and dysglycemia in the second trimester of their pregnancy than those without NAFLD. The findings were based on 476 healthy women who underwent
